BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8880755)

  • 1. Binding of Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2) and related peptides to mu 1 and mu 2 opiate receptors.
    Zadina JE; Paul D; Gergen KA; Ge LJ; Hackler L; Kastin AJ
    Neurosci Lett; 1996 Aug; 215(1):65-9. PubMed ID: 8880755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mu, delta, and kappa opiate receptor binding of Tyr-MIF-1 and of Tyr-W-MIF-1, its active fragments, and two potent analogs.
    Zadina JE; Kastin AJ; Ge LJ; Hackler L
    Life Sci; 1994; 55(24):PL461-6. PubMed ID: 7990646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
    Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
    Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse.
    Watanabe H; Nakayama D; Ito K; Watanabe C; Mizoguchi H; Fujimura T; Murayama K; Kawamura S; Sato T; Sakurada C; Sakurada T; Sakurada S
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1075-81. PubMed ID: 15561796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of a novel tetrapeptide with opiate and antiopiate activity from human brain cortex: Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1).
    Erchegyi J; Kastin AJ; Zadina JE
    Peptides; 1992; 13(4):623-31. PubMed ID: 1359507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analgesic effects of Tyr-W-MIF-1: a mixed mu2-opioid receptor agonist/mu1-opioid receptor antagonist.
    Gergen KA; Zadina JE; Paul D
    Eur J Pharmacol; 1996 Nov; 316(1):33-8. PubMed ID: 8982647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of analogs of the endogenous brain peptides Tyr-MIF-1 and Tyr-W-MIF-1.
    Erchegyi J; Zadina JE; Qiu XD; Kersh DC; Ge LJ; Brown MM; Kastin AJ
    Pept Res; 1993; 6(1):31-8. PubMed ID: 8094991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal Tyr-W-MIF-1 produces potent, naloxone-reversible analgesia modulated by alpha 2-adrenoceptors.
    Gergen KA; Zadina JE; Kastin AJ; Paul D
    Eur J Pharmacol; 1996 Mar; 298(3):235-9. PubMed ID: 8846821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyr-W-MIF-1-induced conditioned place preference.
    Nores WL; Olson RD; Olson GA; Vaccarino AL; Bell RL; Zadina JE; Kastin AJ
    Peptides; 1999; 20(4):479-84. PubMed ID: 10458518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of endomorphin-1, endomorphin-2, and Tyr-W-MIF-1 on activation of G-proteins in SH-SY5Y human neuroblastoma membranes.
    Harrison LM; Kastin AJ; Zadina JE
    Peptides; 1998; 19(4):749-53. PubMed ID: 9622031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyr-MIF-1 and hemorphin can act as opiate agonists as well as antagonists in the guinea pig ileum.
    Zadina JE; Kastin AJ; Kersh D; Wyatt A
    Life Sci; 1992; 51(11):869-85. PubMed ID: 1355851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic analogues of Tyr-W-MIF-1 with prolonged analgesic activity and potency comparable to DAMGO and morphine.
    Zadina JE; Kastin AJ; Hackler L; Chang SL
    Peptides; 1994; 15(8):1567-9. PubMed ID: 7700858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of Tyr-MIF-1 at opiate receptor sites.
    Zadina JE; Kastin AJ
    Pharmacol Biochem Behav; 1986 Dec; 25(6):1303-5. PubMed ID: 2880352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid and antiopioid actions of Tyr-MIF-1, Tyr-W-MIF-1 and hemorphin-4 on rat locus coeruleus neurons: intracellular recording in vitro.
    Yang YR; Chiu TH
    Chin J Physiol; 1997 Sep; 40(3):131-5. PubMed ID: 9434888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemorphins, cytochrophins, and human beta-casomorphins bind to antiopiate (TYR-MIE-1) as well as opiate binding sites in rat brain.
    Zadina JE; Kastin AJ; Ge LJ; Brantl V
    Life Sci; 1990; 47(8):PL25-30. PubMed ID: 1976197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the FOS proto-oncogene protein in brain after ICV administration of Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2).
    Gergen KA; Chang SL; Niu YF; Kastin AJ; Zadina JE
    Peptides; 1994; 15(8):1505-11. PubMed ID: 7700853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of Tyr-W-MIF-1 from bovine hypothalami.
    Hackler L; Kastin AJ; Erchegyi J; Zadina JE
    Neuropeptides; 1993 Mar; 24(3):159-64. PubMed ID: 8097302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From MIF-1 to endomorphin: the Tyr-MIF-1 family of peptides.
    Pan W; Kastin AJ
    Peptides; 2007 Dec; 28(12):2411-34. PubMed ID: 17988762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of a novel peptide with a unique binding profile from human brain cortex: Tyr-K-MIF-1 (Tyr-Pro-Lys-Gly-NH2).
    Hackler L; Kastin AJ; Zadina JE
    Peptides; 1994; 15(6):945-50. PubMed ID: 7991457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous peptide Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1) is transported from the brain to the blood by peptide transport system-1.
    Banks WA; Kastin AJ; Ehrensing CA
    J Neurosci Res; 1993 Aug; 35(6):690-5. PubMed ID: 8105102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.